ondansetron has been researched along with Elevated ICP (Intracranial Pressure) in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cisapride was ineffective at 1 mg/kg but caused a partial reversal at the 5- and 10-mg/kg doses (46." | 1.30 | Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats. ( Gupta, YK; Kacker, V; Mehta, VS, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kacker, V | 1 |
| Mehta, VS | 1 |
| Gupta, YK | 1 |
1 other study available for ondansetron and Elevated ICP (Intracranial Pressure)
| Article | Year |
|---|---|
Acute intracranial hypertension-induced inhibition of gastric emptying: evaluation in conscious rats.
Topics: Acute Disease; Analgesics, Non-Narcotic; Animals; Antihypertensive Agents; Antipsychotic Agents; Bre | 1999 |